MARKET

MBRX

MBRX

Moleculin Biotec
NASDAQ
0.6092
+0.0371
+6.48%
After Hours: 0.6100 +0.0008 +0.13% 19:34 06/02 EDT
OPEN
0.5751
PREV CLOSE
0.5721
HIGH
0.6286
LOW
0.5750
VOLUME
71.81K
TURNOVER
0
52 WEEK HIGH
1.940
52 WEEK LOW
0.5604
MARKET CAP
18.08M
P/E (TTM)
-0.5804
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 2d ago
BRIEF-Moleculin Biotech Announces Adjournment Of 2023 Annual Meeting To June 15, 2023
Reuters · 4d ago
Moleculin Biotec: Current report
Press release · 05/26 12:00
Maxim Group Reaffirms Their Buy Rating on Moleculin Biotech (MBRX)
TipRanks · 05/12 16:26
Earnings Scheduled For May 11, 2023
Benzinga · 05/11 13:58
BRIEF-Moleculin Reports Q1 2023 Financial Results
Reuters · 05/11 12:07
Moleculin Biotech Q1 EPS $(0.28) Misses $(0.25) Estimate, Cash at Q1 $37.3M - Sufficient Capital To Fund Operations Till 3Q24
Benzinga · 05/11 11:12
Moleculin Biotech GAAP EPS of -$0.28 in-line
Seeking Alpha · 05/11 11:08
More
About MBRX
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company. The Company has a pipeline of clinical programs for the treatment of tumors and viruses. It has three core technologies and six drug candidates, three of which have shown human activity in clinical trials. Its core technologies consist of Annamycin, WP1066 Portfolio and WP1122 Portfolio. Annamycin is designed to avoid multidrug resistance mechanisms and cardiotoxicity. Its WP1066 Portfolio (including lead drug candidates WP1066 and WP1220) represents a class of agents capable of hitting multiple targets, including the activated form of a key oncogenic transcription factor, STAT3. WP1066 is its flagship Immune/Transcription Modulator. An analog of WP1066, referred to as WP1220, is related to the use of the molecule in the topical treatment of psoriasis. Annamycin is in development for the treatment of refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases.

Webull offers kinds of Moleculin Biotech Inc stock information, including NASDAQ:MBRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MBRX stock methods without spending real money on the virtual paper trading platform.